B7-H4 詳細
Molecule Name
V-set domain-containing T-cell activation inhibitor 1
分子の別称
B7-H4,VTCN1,B7S1,B7h.5
Drug Development Progress
治験薬の数11
市販薬剤の数0
研究＆開発段階Phase 3 Clinical
ターゲットの別称
V-Set Domain-Containing T-Cell Activation Inhibitor 1，Immune costimulatory protein B7-H4，B7h.5，B7 homolog 4，T-cell costimulatory molecule B7x，V-Set Domain Containing T Cell Activation Inhibitor 1，B7X，B7 Family Member， H4，T Cell Costimulatory Molecule B7x，B7S1，B7 Superfamily Member 1，VCTN1，PRO1291，FLJ22418，B7H4，B7-H4，Protein B7S1
バックグランド
V-set domain-containing T-cell activation inhibitor 1 (VTCN1) is also known as Immune costimulatory protein B7-H4, Protein B7S1, T-cell costimulatory molecule B7x, B7H4, which belongs to the immunoglobulin superfamily and BTN/MOG family. VTCN1 contains two Ig-like V-type (immunoglobulin-like) domains. The expression of VTCN1 is up-regulated by IL6 and IL10 and is inhibited by GM-CSF and IL4 on antigen-presenting cells (APCs). VTCN1 / B7-H4 negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. VTCN1 involved in promoting epithelial cell transformation.
B7-H4 製品リスト
You Have Viewed 0 Of 0 Results
1***12019-11-16We purchased total of 600ug of this biotin-labeled antigen for liquid phase panning and antibody screening of affinity maturation. This antigen has good stability, high quality, and high repeatability for each experiment. Using this antigen, we screened high-affinity antibodies against this target. And using this antigen for screening of affinity maturation, we obtained antibodies with 10-times increased affinity. I highly recommended this product.